Blueprint Medicines (GB:0HOJ)
LSE:0HOJ
Holding GB:0HOJ?
Track your performance easily

Blueprint Medicines (0HOJ) Similar Shares

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Blueprint Medicines
$5.72B
-26.37
74.24%
9 Buy
4 Hold
0 Sell
Moderate Buy
Blueprint Medicines
$5.72B
-26.37
74.24%
9 Buy
4 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$35.01B
-453.27
55.80%
16 Buy
6 Hold
0 Sell
Moderate Buy
Crispr Therapeutics AG
$3.99B
-14.50
-0.41%
10 Buy
6 Hold
2 Sell
Moderate Buy
Kura Oncology
$1.52B
-8.78
131.87%
9 Buy
1 Hold
0 Sell
Strong Buy
FibroGen
$38.52M
-0.22
-57.17%
0 Buy
0 Hold
1 Sell
Moderate Sell

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
GB:0HOJ
Blueprint Medicines
89.13
39.05
77.98%
BPMC
Blueprint Medicines
87.00
37.07
74.24%
ALNY
Alnylam Pharma
272.73
97.68
55.80%
CRSP
Crispr Therapeutics AG
45.92
-0.19
-0.41%
KURA
Kura Oncology
19.57
11.13
131.87%
FGEN
FibroGen
0.37
-0.50
-57.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis